Back to resultsAbdominal MR Imaging at 3.0T: Sequence Optimization and Implementation
Primary Purpose
Diffuse and Focal Abnormalities of the Liver and Pancreas
Status
Terminated
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Body MR imaging
Sponsored by
About this trial
This is an interventional diagnostic trial for Diffuse and Focal Abnormalities of the Liver and Pancreas
Eligibility Criteria
Inclusion Criteria:
- Subjects between ages of 19 and 65
- Healthy volunteer subjects should not have any history of disease or symptoms - based on clinical history
- Subjects with an underlying disorder (diffuse and focal abnormalities of the liver and pancreas)
Exclusion Criteria:
- Inability to provide informed consent
- A medical or contraindications that will prevent subjects from having a MRI
- Subjects with severe renal dysfunction or patients on dialysis
Sites / Locations
- University of Nebraska Medical Center
- University of Nebraska Medical Center
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
Body MRI healthy volunteers
Arm Description
Body MRI to optimize sequences in healthy individuals and in disorder subjects
Outcomes
Primary Outcome Measures
Optimizing body MR imaging sequences
Healthy volunteers will be used to obtain optimized body MR imaging sequences that will then be used to evaluate MR imaging sequences of subjects with underlying disorders.
Secondary Outcome Measures
Full Information
NCT ID
NCT01007357
First Posted
October 28, 2009
Last Updated
July 12, 2023
Sponsor
University of Nebraska
Collaborators
Philips Medical Systems
1. Study Identification
Unique Protocol Identification Number
NCT01007357
Brief Title
Abdominal MR Imaging at 3.0T: Sequence Optimization and Implementation
Official Title
Abdominal MR Imaging at 3.0T: Sequence Optimization and Implementation
Study Type
Interventional
2. Study Status
Record Verification Date
July 2023
Overall Recruitment Status
Terminated
Why Stopped
Principal Investigator left institution; did not complete the study
Study Start Date
December 15, 2009 (Actual)
Primary Completion Date
June 30, 2015 (Actual)
Study Completion Date
June 30, 2015 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Nebraska
Collaborators
Philips Medical Systems
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
This project will facilitate the optimization of body MR imaging at 3 Tesla.
Detailed Description
This project is meant to improve the image quality of multiple sequences at 3.0T applied to the abdominal and pelvic regions.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diffuse and Focal Abnormalities of the Liver and Pancreas
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
25 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Body MRI healthy volunteers
Arm Type
Other
Arm Description
Body MRI to optimize sequences in healthy individuals and in disorder subjects
Intervention Type
Device
Intervention Name(s)
Body MR imaging
Other Intervention Name(s)
Body MR imaging performed to optimize sequences
Intervention Description
Body MR imaging will be performed to optimize sequences
Primary Outcome Measure Information:
Title
Optimizing body MR imaging sequences
Description
Healthy volunteers will be used to obtain optimized body MR imaging sequences that will then be used to evaluate MR imaging sequences of subjects with underlying disorders.
Time Frame
2 years
10. Eligibility
Sex
All
Minimum Age & Unit of Time
19 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Subjects between ages of 19 and 65
Healthy volunteer subjects should not have any history of disease or symptoms - based on clinical history
Subjects with an underlying disorder (diffuse and focal abnormalities of the liver and pancreas)
Exclusion Criteria:
Inability to provide informed consent
A medical or contraindications that will prevent subjects from having a MRI
Subjects with severe renal dysfunction or patients on dialysis
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Shahid Hussain, MD
Organizational Affiliation
University of Nebraska
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Nebraska Medical Center
City
Omaha
State/Province
Nebraska
ZIP/Postal Code
68198-1045
Country
United States
Facility Name
University of Nebraska Medical Center
City
Omaha
State/Province
Nebraska
ZIP/Postal Code
68198
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Abdominal MR Imaging at 3.0T: Sequence Optimization and Implementation
We'll reach out to this number within 24 hrs